| Policy Name: | Disallowed Treatment Modalities Policy |
| Effective Date: | 01/01/2026 |
| Review/Approval Date: | 12/17/2025 |
| Revision Date: | 03/17/2026; 08/20/2026; 08/31/2026 |
| Approved By: | Medical Director |
Purpose:
To facilitate the delivery of safe, evidence-based behavioral health care through Headway's platform, ensure patient safety and clinical integrity, and maintain compliance with payer and regulatory requirements by defining permitted and prohibited treatment modalities.
Applicability:
Therapymatch, Inc., d/b/a as Headway, and its affiliates and subsidiaries (collectively, "Headway," "we," "us," or "our") and all of its associated Professional Corporations (PCs), including but not limited to all current and future PCs.
Definitions:
- Behavioral Health Treatment — Interventions intended to diagnose, treat, or manage mental health or substance use conditions as defined by the DSM-5 or equivalent clinical standards.
- Evidence-Based — Supported by credible scientific research demonstrating safety and efficacy and recognized by professional associations, licensing bodies, and/or payers.
- Non-Behavioral Health Interventions — Services primarily intended to treat physical health conditions, cosmetic or aesthetic concerns, or other non-behavioral health needs.
- Adjunctive Intervention — A supportive or complementary practice used in conjunction with, and subordinate to, an evidence-based behavioral health treatment modality.
Policy:
Headway permits only treatment modalities and interventions that are evidence-based, clinically appropriate for behavioral health care, and, when services are billed through a payer, eligible for reimbursement. Providers may not deliver, promote, advertise, document, or bill for interventions that fall outside recognized standards of behavioral health practice, including alternative, spiritual, energy-based, pseudoscientific, or non-clinical practices lacking credible scientific support.
Headway does not permit the provision or promotion of substance-assisted psychotherapy on its platform, including psychotherapy in which psychoactive substances are intentionally administered or present during treatment sessions. This list is non-exhaustive and may be updated as new substances or modalities emerge.
Procedures:
-
General Expectations for Providers
- Deliver only treatment modalities supported by credible evidence of safety and efficacy within accepted behavioral health scope.
- Do not offer, promote, advertise, document, or bill for unsupported, non-evidence-based, or non-reimbursable modalities on the Headway platform.
- Ensure all billed services are eligible for reimbursement under applicable payer guidelines.
- Do not conduct, advertise, or document interventions primarily intended for physical health, cosmetic, or aesthetic purposes.
- When a patient may benefit from non-behavioral health or prohibited services, refer the patient to an appropriate outside provider.
-
Prohibited Treatment Modalities
- Conversion-adjacent or coercive practices: Conversion therapy or any practice aimed at changing sexual orientation or gender identity; coercive or shame-based behavioral interventions related to identity; purging behaviors or facilitation of eating-disorder compensatory behaviors.
- Discredited or non-evidence-based psychotherapeutic practices: Primal therapy; Past Lives Regression therapy; Rebirthing therapy; Recovered memory-based therapy; Hypnoanalysis; Neuro-Linguistic Programming; Attachment holding therapy.
- Substance-assisted or psychoactive-facilitated psychotherapy: Including cannabis, psilocybin, MDMA, ketamine, esketamine (Spravato), oxytocin for psychotherapeutic purposes, and other psychedelic agents used during a psychotherapy session.
- Energy, spiritual, or pseudoscientific healing practices: Aura healing; chakra healing; crystal healing; gemstone therapy; vibrational essences; flower essences; Reiki; therapeutic touch; polarity therapy.
- Discredited or dangerous medical interventions: Antineoplastons; Coley's toxin; Laetrile; hydrazine sulfate; hydrogen peroxide therapy; ozone therapy; ultraviolet blood irradiation; Revici's guided chemotherapy; 714-X.
- Sexualized or erotic practices framed as therapy: Yoni practices; lingam practices.
- Aesthetic interventions: Weight-loss pharmacotherapy or procedures (except when clinically indicated to address weight gain caused by a behavioral health condition or its treatment); cosmetic procedures including Botox, fillers, or laser treatments.
- Out-of-scope treatments: Hormonal treatments for minors (< 18) including testosterone, androgen-blockers, estrogens, progesterone, or GnRH analogues.
- Illegal treatments: Any treatment prohibited under applicable laws in the state or locality where the provider is practicing.
-
Restricted / Non-Standalone Interventions
- The following may not be offered, documented, promoted, or billed as standalone or primary services. They may be used only as adjunctive supports when an evidence-based behavioral health treatment is clearly documented as the primary modality:
- Expressive or experiential therapies: Dance/movement therapy; music therapy; psychodrama; therapeutic eurythmy.
- Mind-body or somatic adjuncts: Guided imagery; humor therapy; hypnosis; Trager approach; Feldenkrais method; Alexander technique; autogenic training.
- Complementary practices with limited mental health evidence: Aromatherapy; acupressure; reflexology; craniosacral therapy; Gua Sha; cupping; Tui Na; moxibustion.
- Movement-based wellness practices: Pilates; yoga; qigong.
- Technology-adjacent interventions: Vibro-acoustic therapy; whole body vibration; weighted blankets for panic/anxiety.
- Non-behavioral health medical interventions: IV vitamin/nutrient/hydration therapy; hormone replacement therapy.
- The following may not be offered, documented, promoted, or billed as standalone or primary services. They may be used only as adjunctive supports when an evidence-based behavioral health treatment is clearly documented as the primary modality:
-
Accountability and Oversight
- Providers found to be in violation of this Policy may be subject to corrective action, including education, monitoring, suspension, or termination of the provider's contractual relationship with Headway.
References: